Company intelligence / Profile preview

Ancora Finance Group

Ownership: Private
Development stage: Other

Overview

Ancora Finance Group is an investment and corporate finance advisory firm focused on providing growth capital to innovative European companies in the environmental and healthcare sectors. It develops proprietary technology-led investment strategies and offers advice for both private and public equity funds. The group leverages AI-driven analytics to support its investment activities. It does not develop therapeutics or have a clinical pipeline. The company was founded in 2012 and has offices in London, Munich, and Zurich. Regulated by the FCA for investment/corporate finance advisory through its subsidiary, Ancora Finance LLP.

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships as an operator; acts as investor/advisor.

Beyond the preview

Go deeper on Ancora Finance Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ancora Finance Group.

Explore the full profile